Hong Kong pharmaceutical ETF Yinhua has fallen by over 20% in the past year, with a current negative discount rate of 0.32%, and is in a low-risk zone

2026-08-17 09:59

Economic Observation Network The latest share of the Hong Kong pharmaceutical ETF Yinhua (159776) fund is 83 million shares, with a cumulative decrease of 36 million shares over the past three years. The latest scale is 98 million yuan, with a cumulative decrease of 19 million yuan in the past three years.

The fund has fallen 20.41% in the past year, with a maximum drawdown of 37.45%. The current ETF yield is -0.32%, exceeding the historical time of 18%, and it is in a low-risk zone with a small deviation from net asset value and a high margin of safety.

The above content is based on publicly available information and does not constitute investment advice.